In addition, GYY4137 suppressed HCC cell’s viability time- and dose-dependently and suppressed the angiogenesis by downregulating the levels of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α) that were STAT3 downstream proteins. This evidence concerns the gene VEGFA and hepatocellular carcinoma.